SCHEMBL21687481

SCHEMBL21687481

N#Cc1ccc2c(c1)c1cc(C#N)ccc1n2-c1cc(-c2ccccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)ccc1C#N

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.31
AR P10275 1/20 0.31
ALDH1A1 P00352 2/20 0.30
LMNA P02545 2/20 0.30
HPGD P15428 2/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ALOX5AP P20292 1/20 0.30
FEN1 P39748 1/20 0.30
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30
KDM4E B2RXH2 2/20 0.30
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30
HSD17B10 Q99714 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688105 0.97 PTGER4 (0.33) NR3C1CYP11B1CYP11B2
SCHEMBL21687705 0.91 GABRA1 (0.32) NR3C1ALDH1A1LMNAHPGDALOX5AP
SCHEMBL21687749 0.91 PTGER4 (0.33) CYP11B1CYP11B2
SCHEMBL21688174 0.91 PTGER4 (0.33) CYP11B1CYP11B2
SCHEMBL21687896 0.89 PTGER4 (0.33) NR3C1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL21687561 0.89 PTGER4 (0.31) ALDH1A1MAPK1SMN1; SMN2MEN1CYP1A2
SCHEMBL21687984 0.89 CYP11B2 (0.34) NR3C1ARALDH1A1LMNAHPGD
SCHEMBL21687700 0.87 NR3C1 (0.31) NR3C1ALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL21688056 0.87 CYP11B1 (0.32) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL21687712 0.86 CYP11B1 (0.34) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 NR3C1 667/4885AR 1928/4885ALDH1A1 616/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 NR3C1 667/4885AR 1928/4885ALDH1A1 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.